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Abstract
Introduction: Dengue is one of the most widespread mosquito-borne diseases in the world. The causative agent, dengue
virus (DENV), is primarily transmitted by the mosquito Aedes aegypti, a species that has proved difficult to control using
conventional methods. The discovery that A. aegypti transinfected with the wMel strain of Wolbachia showed limited DENV
replication led to trial field releases of these mosquitoes in Cairns, Australia as a biocontrol strategy for the virus.
Methodology/Principal Findings: Field collected wMel mosquitoes that were challenged with three DENV serotypes
displayed limited rates of body infection, viral replication and dissemination to the head compared to uninfected controls.
Rates of dengue infection, replication and dissemination in field wMel mosquitoes were similar to those observed in the
original transinfected wMel line that had been maintained in the laboratory. We found that wMel was distributed in similar
body tissues in field mosquitoes as in laboratory ones, but, at seven days following blood-feeding, wMel densities increased
to a greater extent in field mosquitoes.
Conclusions/Significance: Our results indicate that virus-blocking is likely to persist in Wolbachia-infected mosquitoes after
their release and establishment in wild populations, suggesting that Wolbachia biocontrol may be a successful strategy for
reducing dengue transmission in the field.
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Introduction
Dengue is one of the most common and widespread vector-
borne diseases in the world, with up to 380 million infections
estimated to occur annually [1]. The causative agent, dengue virus
(DENV), has expanded its geographic range in the last two
decades, with more than 100 countries now affected. Infection
with DENV leads primarily to self-limiting fevers but recent
decades have seen a marked increase in severe dengue, with
manifestations such as hypovolemic shock and hemorrhage [2].
DENV is transmitted primarily by the mosquito vector Aedes aegypti
and, to a lesser extent, by its congener A. albopictus. In the absence
of an effective vaccine [3] and/or antivirals, prevention of dengue
transmission relies primarily on control of mosquito vectors. The
failure to prevent the global spread of dengue, increasing
insecticide resistance in mosquito populations and subsequent
escalating costs of insecticide-based programs, as well as environ-
mental concern over the impact of these chemicals, have spurred
the development of novel, inexpensive and green vector control
methods [4,5].
The transinfection of vector mosquitoes with the bacterium
Wolbachia pipientis has emerged as a promising method for the
control of dengue. Wolbachia is the most common endosymbiont of
insects, thought to infect up to 40% of arthropod species [6].
A. aegypti stably transinfected with different strains of Wolbachia
show reduced replication and transmission of DENV [7–9]. An
additional advantage of using Wolbachia for biocontrol of DENV is
the ability of the bacterium to propagate through a population
by inducing cytoplasmic incompatibility (CI) in its host [10].
CI confers a fitness advantage to Wolbachia-infected females that
allows these maternally transmitted bacteria to spread unaided
through a population [10]. The use of Wolbachia provides a means
of biocontrol that is both pesticide-free and poses minimal envi-
ronmental safety concerns [11].
In laboratory trials, mosquitoes with the wMel strain of
Wolbachia showed both blocking of DENV transmission and
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minimal fitness effects due to infection with the bacterium [9]. In
addition, wMel rapidly invaded wildtype mosquito populations in
semi-field cage experiments due to CI and minimal fitness costs
[9]. The results facilitated the field release of wMel-infected
mosquitoes in two suburbs of Cairns, Queensland, Australia [12].
Within a short period, the frequency of wMel reached fixation in
the two suburbs [12] and has remained established at both sites.
The persistence of the viral-blocking phenotype in field popu-
lations is fundamental to the utility of releases of Wolbachia-infected
mosquitoes. The mechanisms that underpin viral interference are
poorly understood but may be related to the density of Wolbachia
[13,14], immune pre-activation [7,8,15], intra-host competition
for cellular resources [16,17] or suppression of host cellular factors
that are upregulated during viral infection [18]. The density of
Wolbachia may decrease after several generations, as happened
following the transinfection of the virulent strain of wMelPop
into the novel host Drosophila simulans [19]. Wolbachia infection
frequencies and associated CI effects may also be significantly
lower in nature than observed in the lab, as observed in Drosophila
simulans [20]. However, the wMel strain is avirulent and has
limited negative effects on mosquito fitness in the laboratory [9],
suggesting that the density of the wMel strain may remain stable
over time. Protection against RNA virus-induced mortality was
in fact first observed in the long term, evolutionarily stable
association between wMel and its Drosophila melanogaster host [21].
Here, we investigated the extent of virus blocking in field wMel-
infected A. aegypti, one year following field release, using three
serotypes of DENV. We found limited replication and dissemina-
tion of DENV in field wMel mosquitoes, indicating stability of the
viral-blocking phenotype in wild Wolbachia-infected mosquitoes.
The extent of virus blocking was similar in field mosquitoes
compared to the original, wMel-infected, outcrossed lab line used
for release. Interestingly, the density of Wolbachia increased
following blood feeding and to a greater extent in field versus
lab wMel-infected mosquitoes. We suggest that if the viral blocking
effect of field wMel is dependent on Wolbachia density, repeated
blood feeding on human hosts might amplify this effect. Our
results reinforce the utility of Wolbachia-based technology for bio-
control of dengue.
Methods
Ethics statement
Blood feeding of mosquito colonies using human volunteers was
performed in accordance to Monash University Human Research
Ethics Committee permit CF11/0766-2011000387. Written in-
formed consent was obtained from all volunteers who participated
in the study. Dengue viremic plasma was obtained from patients
enrolled in a prospective study at the Hospital for Tropical
Diseases, Ho Chi Minh City, Vietnam. All patients provided
written consent to participate in the study. The study protocols
relevant to this work, including vector competence experiments,
were reviewed and approved by the Scientific and Ethical
Committee of the Hospital for Tropical Diseases (CS/ND/09/
24) and the Oxford Tropical Research Ethical Committee
(OxTREC 20-09). The inclusion criteria were: a) adult patients
($15 years of age), with #72 hours of fever and suspected of
having dengue based on clinical symptoms, b) a positive NS1
Rapid test and c) written informed consent. All plasma samples
were anonymized (samples were identified using numbers only)
prior to experiments.
Mosquito colony establishment and maintenance
Mosquito eggs were collected in January 2012 from ovitraps
placed inside the Wolbachia release zone in the Cairns suburbs of
Yorkey’s Knob and Gordonvale and outside, in Edge Hill,
Whitfield, Edmonton and Bentley Park. Eggs collected from
outside the Wolbachia release zone were Wolbachia-uninfected. Eggs
on ovistrips were allowed to hatch and larvae reared in water
supplemented with fish food pellets (Tetramin, Tetra). Fourth
instar larvae were identified as A. aegypti based on specific
morphological characters. Adults (F0) emerged in cages of
approximately 450 individuals and were allowed to feed on 10%
sucrose ad libitum. Five to seven day old females were allowed to
feed on human volunteers and eggs were collected from several
gonotrophic cycles. F1 adults hatched from eggs obtained in the
first gonotrophic cycle were used in vector competence experi-
ments. The wMel-infected field mosquito line and its uninfected
counterpart (derived from Wolbachia-uninfected eggs) were denot-
ed wMel.F and wildtype, respectively. The original laboratory-
reared, outcrossed wMel-infected MGYP2.out line [9] was used in
some experiments. All mosquito colonies were kept at 26uC under
a 12L:12D light cycle and 60% relative humidity.
Virus strains
Mosquitoes were challenged in vector competence experiments
with virus strains belonging to DENV serotypes 1–3, using virus
grown in cell culture and viremic plasma from human patients.
DENV-2 strain 92T and DENV-3 strain Cairns 2008 (both
isolated from outbreaks in north Queensland, Australia in 1992
and 2008, respectively) were grown in C6/36 cells and harvested
and titered as described previously [13]. Virus was aliquoted in
single-use 1 mL lots and stored at 280uC.
Vector competence experiments
Two separate vector competence experiments were carried out
to determine if DENV could replicate and disseminate in field
wMel-infected mosquitoes. For both experiments, female mosqui-
toes (5–7 days old) were allowed to feed on viremic blood meals
contained in a membrane feeder with sheep intestine as the
membrane. Virus was mixed with defibrinated sheep blood to
Author Summary
Almost half of the world’s population is at risk of
contracting dengue virus, particularly in the tropics and
sub-tropics. The virus is transmitted by the mosquito Aedes
aegypti, a cosmopolitan species that has proved difficult to
control using traditional methods. A new biocontrol
strategy has been developed involving the release of
mosquitoes infected with Wolbachia bacteria. Mosquitoes
with the wMel strain of Wolbachia show dramatically
reduced replication and transmission of dengue virus in
laboratory trials. Although promising, the utility of
Wolbachia biocontrol depends on field wMel-infected
mosquitoes retaining the phenotype of reduced viral
replication. Mosquitoes with wMel were released in the
field in Cairns, Australia in early 2011. We provide evidence
that, one year later, field collected wMel mosquitoes
showed reduced dengue virus replication in the body and
limited dissemination to the head compared to controls.
Wolbachia numbers in mosquitoes increased following
blood meals, which may further decrease viral replication if
the insects feed frequently. Our results indicate that
Wolbachia-mediated dengue interference is sustained in
field populations and shows no sign of attenuation after
one year of deployment.
DENV Replication in Field Wolbachia Mosquitoes
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obtain final bloodmeal titers (see below). Mosquitoes were allowed
to feed for 1 hour, with engorged females separated from unfed
ones the next day. Females were kept in plastic cups at a density
of 10–12 individuals/cup and allowed access to 10% sucrose
ad libitum. Females were killed under CO2 at either 7 or 14 days
post infection (p.i.), immediately frozen in dry ice and stored at 2
80uC until further processing.
In the first experiment, field wMel and uninfected mosquitoes
were challenged with two viremic plasma samples from Vietnam,
DENV-1 – P249 (final titer 7.38E+08 genomic copies/mL) and
DENV-2 – P410 (final titer 1.12E+09 genomic copies/mL), as well
as a cell-culture grown virus isolated in Australia, DENV-2 – 92T
(9.30E+09 copies/mL) as a control. In the second experiment, the
field wMel-infected and two control lines, MGYP2.out [9] and
field Wolbachia-uninfected wildtype, were challenged with a viremic
human plasma sample from Vietnam, DENV-1-P307 (2.46E+11
copies/mL), and two virus strains isolated in Australia, DENV-2-
92T (9.30E+09 copies/mL) and DENV-3-Cairns 2008 (3.58E+09
copies/mL). Human viremic plasmas underwent a single freeze-
thaw cycle before use in vector competence experiments.
RNA extraction and qRT-PCR for DENV
RNA was extracted from mosquito bodies using Trizol reagent
(Invitrogen), and from heads using the QIAamp viral RNA mini
kit (Qiagen), following homogenization of tissues with 3 mm glass
beads in a Beadbeater. A higher yield of total RNA was obtained
on average from head samples using the QIAamp viral RNA mini
kit versus Trizol (F. Frentiu, unpublished data). For mosquitoes
challenged with Vietnamese viremic plasmas, virus genome copies
were estimated by qRT-PCR using FAM-labeled DENV-1
and DENV-2 hydrolysis probe sequences and standard curves
from reference [22]. Virus copies in mosquitoes challenged with
DENV-2-92T and DENV-3-Cairns 2008 were estimated by qRT-
PCR, using hydrolysis probes specific to the 39UTR region.
Primer sequences were F: 59-AAGGACTAGAGGTTAGAGGA-
GACCC-39 and R: 59-CGTTCTGTGCCTGGAATGATG-39,
with probe sequence: 59- FAM- AACAGCATATTGACGCTGG-
GAGAGACCAGA-BHQ1-39. Reactions were performed with the
SuperScriptH III PlatinumH One-Step qRT-PCR kit (Invitrogen)
and contained 5 mL of RNA template, 5 mM each of probe and
forward and reverse primers, buffer and enzyme as per kit
instructions, in a total volume of 20 mL. For head qPCRs, 10 mL of
RNA template was used, with water adjusted accordingly. The
number of DENV copies was calculated following a standard
curve for DENV 39UTR, constructed as in [8]. All reactions were
performed using a LightCycler480 Instrument (Roche) with the
following run conditions: 50uC for 15 min, 95uC for 2 min,
followed by 45 amplification cycles of 95uC for 15 s, 60uC for 30 s
and a final cooling step of 40uC for 10 s.
Reactions were run in duplicate and samples where DENV
failed to amplify in at least one replicate were classified as zero.
Only samples where DENV amplified in both technical replicates
and the amount of copies extrapolated by the LightCycler software
was above the lower bound of the standard curve (limit of
detection) were included in the analysis. All mosquitoes from field
and lab wMel-infected lines that showed DENV breakthrough
were tested for the presence of Wolbachia using IS5 repeat primers
specific to the wMel and wMelPop strains [23]. Only one sample
each from the field and lab wMel-infected mosquitoes was negative
for Wolbachia. These samples were excluded from further analysis.
DNA extraction and quantification of Wolbachia density
The densities of Wolbachia were compared between field and lab
strains of wMel-infected mosquitoes in a separate experiment. Five
to seven-day old females from each line were fed on a mix of
DENV-3 – Cairns 2008 and sheep blood and collected at 7 and 14
days post infection (as detailed above) for genomic DNA extrac-
tion. Control non-blood fed females from each line were main-
tained in parallel and collected at the same time points. Genomic
DNA was extracted using the DNAEasy Blood and Tissue kit
(Qiagen) as per the manufacturer’s instructions. A multiplex qPCR
amplifying the target Wolbachia-specific wsp and mosquito house-
keeping RpS17 [24] genes was performed (wsp F: 59-CATTG-
GTGTTGGTGTTGGTG-39, R: 59-ACACCAGCTTTTACTT-
GACCAG-39, probe: 59-HEX-TCCTTTGGAACCCGCTGTG-
AATGA-BHQ1-39; RpS17 F: 59-TCCGTGGTATCTCCAT-
CAAGC-39, R: 59-CACTTCCGGCACGTAGTTGTC-39, probe:
59-FAM-CAGGAGGAGGAACGTGAGCGCAG-BHQ1-39).The
RpS17 housekeeping gene was used to normalize wsp gene copies.
qPCR reactions were performed in 10 mL total volume containing
16Lightcycler 480 Probes Master reaction mix, 5 mM each of wsp
primers and probe, 2.5 mM each of RpS17 primers and probe and
1 mL of DNA template. Cycling was performed using a Light-
Cycler480 Instrument (Roche), with 1 cycle at 95uC for 5 min,
followed by 45 amplification cycles of 95uC for 10 s, 60uC for 15 s,
72uC for 1 s, and a final cooling cycle of 40uC for 10 s. Target to
housekeeping gene ratios were calculated using the Relative
Quantification algorithm in the Lightcycler 480 software (Roche).
Fluorescence in-situ hybridization (FISH)
Tissue localization of wMel in field wMel.F and lab MGYP2.out
mosquitoes was visualized using FISH. Females were collected
under CO2 and immediately placed overnight in 4% paraformal-
dehyde at 4uC with their wings and legs removed. Paraffin-
embedded mosquitoes were sectioned in 8 mM thin slices. Slides
were de-paraffinated in 100% xylene, rehydrated in an ethanol
series and hybridized overnight at 37uC in a buffer containing
Wolbachia-specific W2 and W3 probes [8]. Post-hybridization pro-
cessing followed [8]. Slides were mounted using an antifade
reagent (Prolong Gold, Invitrogen) and viewed with a Zeiss Axio
Imager II epifluorescence microscope equipped with an Axiocam
camera, using the same exposure conditions for each filter
channel.
Statistical analysis
Differences between mosquito lines in DENV infection rates for
both vector competence experiments were analyzed using pairwise
Table 1. Rates of infection (%) for three DENV strains
between field Wolbachia-infected (wMel.F) and uninfected
(wildtype) mosquito lines at days 7 and 14 p.i. (experiment 1).
Body infection (N) Head infection (N)
wildtype wMel.F wildtype wMel.F
day 7 p.i.
DENV1 – P249 44 (18) 19 (16) 44 (18) 6 (16)
DENV2 – 92T 26 (21) 0 (18) 10 (21) 0 (17)
DENV2 – P410 79 (14) 6 (31)*** 62 (13) 3 (31)***
day 14 p.i.
DENV1 – P249 41 (17) 4 (25)* 35 (17) 0 (25)***
DENV2 – 92T 53 (19) 7 (28)* 47 (19) 4 (28)***
DENV2 – P410 94 (16) 3 (30)* 62 (13) 3 (30)***
Adjusted Fisher’s exact test p-values,0.05 (*), ,0.001 (***).
doi:10.1371/journal.pntd.0002688.t001
DENV Replication in Field Wolbachia Mosquitoes
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Fisher’s exact tests. P-values were adjusted for multiple compar-
isons for each day of sampling within each experiment using
the Holm method [25], with values ,0.05 considered significant.
In experiment 1, differences in median DENV copy numbers
between lines were analyzed using Mann-Whitney U tests. In
experiment 2, differences among the three lines in copies of each
virus were analyzed using Kruskal-Wallis tests, with Dunn’s post-
hoc multiple comparison tests. Last, we tested for significant
Figure 1. Experiment 1: DENV replication in wildtype and field-released (wMel.F) A. aegypti. DENV replication in bodies (A) and heads (B)
of mosquitoes challenged with three strains (DENV2-92T, DENV1-P249, DENV2-P410), assayed at 14 days post-infection. DENV levels determined
using one-step qRT-PCR and expressed as copies per 1 mg of total RNA. Bars denote medians. P,0.05 (*), P,0.01 (**), P,0.001 (***). Each point
represents an individual mosquito.
doi:10.1371/journal.pntd.0002688.g001
Table 2. Rates of infection (%) for three DENV strains among field (wMel.F) and laboratory Wolbachia-infected (MGYP2.out) and
uninfected (wildtype) mosquito lines at days 7 and 14 post-infection (p.i.) (experiment 2).
Body infection (N) Head infection (N)
wildtype wMel.F MGYP2.out wildtype wMel.F MGYP2.out
day 7 p.i.
DENV1 – P307 23(13) 12 (17) 10 (21) 8 (13) 6 (17) 5 (21)
DENV2 – 92T 54 (13) 0 (16)* 13 (15) 8 (12) 0 (16) 7 (15)
DENV3 – Cairns08 58 (12) 6 (17)* 14 (14) 25 (12) 0 (17) 7 (14)
day 14 p.i.
DENV1 – P307 65 (17) 15 (20)* 41 (17) 65 (17) 5 (20)*** 29 (17)
DENV2 – 92T 77 (13) 12 (17)* 13 (15) 69 (13) 6 (17)*** 7 (14)
DENV3 – Cairns08 92 (13) 6 (17)*** 9 (22) 77 (13) 6 (17)*** 0 (22)
Adjusted Fisher’s exact test p-values,0.05 (*), ,0.001 (***). P-values shown refer to comparisons between wildtype and wMel.F mosquitoes.
doi:10.1371/journal.pntd.0002688.t002
DENV Replication in Field Wolbachia Mosquitoes
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differences in Wolbachia density between MGYP2.out and wMel.F
mosquitoes using Mann-Whitney U tests. All analyses were per-
formed in R [26] and GraphPad Prism v. 6 (GraphPad Software,
San Diego, California USA).
Results
Limited DENV infection and replication in field wMel-
infected mosquitoes
We conducted two independent experiments to assess rates of
DENV infection and replication in wildtype and wMel-infected
field release mosquitoes. In experiment 1, at day 7 p.i., lower rates
of body and head infection were detected in field wMel mosquitoes
compared to wildtype for the two DENV-1 and DENV-2 viremic
plasma samples and cell culture DENV-2-92T virus strains
(Table 1). However, only for DENV-2 strain P410, a viremic
plasma sample, was there a statistically significant difference
between the two mosquito lines (Table 1). At day 14 p.i., rates of
body and head infection were significantly lower in field wMel
compared to wildtype mosquitoes for all three DENV strains, with
a stronger effect in dissemination to heads (Table 1). The highest
observed dissemination rate in wMel.F heads was a low 6%,
compared to 62% in wildtype heads. DENV genome copy titers in
heads and bodies were uniformly higher for all strains in wildtype
mosquitoes compared to respective wMel.F samples at day 14 p.i.
(Figure 1). For example, titers in both bodies and heads typically
reached 16108 copies for all virus strains in wildtype individuals.
By contrast, most wMel.F individuals showed an absence of
DENV replication (Figure 1). A similar difference in virus titers
was present at day 7 p.i., but to a lesser extent because of low
infection rates (Figure S1).
We next investigated whether vector competence was similar in
field wMel-infected A. aegypti compared to the original wMel-
infected line that had been maintained in the lab with recurrent
outbreeding [9]. In experiment 2, we estimated DENV infection
rates and replication titers for three virus strains in wildtype,
wMel.F and MGYP2.out mosquitoes. We tested for statistically
significant differences in infection rates only between wildtypes
and wMel.F, and between wMel.F and MGYP2.out mosquitoes
(Table 2). At day 7 p.i., significantly lower body infection rates
were found in wMel.F mosquitoes versus wildtypes for DENV-2-
92T and DENV-3-Cairns08 strains (Table 2). However, rates of
infection across all mosquito lines and all viruses were low in
general, resulting in limited power for robust statistical tests. At
day 14 p.i., significantly different infection rates between wildtypes
and wMel.F mosquitoes were found for both bodies and heads
across all DENV strains (Table 2). For both experiments 1 and 2,
dissemination of all virus strains by day 14 p.i. was dramatically
lower in field wMel mosquitoes compared to wildtypes. There
were no significant differences in infection rates between wMel.F
and MGYP2.out mosquitoes across either day post-infection.
DENV titers were significantly lower across all virus strains in
both heads and bodies in field wMel mosquitoes compared to
wildtypes, at day 14 post-infection (Figure 2). A similar pattern
was observed at day 7 post-infection, although only for bodies and
the strains DENV-2-92T and DENV-2-Cairns08/09 (Figure S2).
Figure 2. Experiment 2: DENV replication in wildtype, outbred laboratory wMel (MGYP2.out) and field-released wMel (wMel.F) A.
aegypti. DENV replication in bodies (A) and heads (B) of mosquitoes challenged with three strains (DENV2-92T, DENV1-P307, DENV3-Cairns08/09),
assayed at 14 days post-infection. DENV levels determined using one-step qRT-PCR and expressed as copies per 1 mg of total RNA. Bars denote
medians. P,0.05 (*), P,0.01 (**), P,0.001 (***). Each point represents an individual mosquito.
doi:10.1371/journal.pntd.0002688.g002
DENV Replication in Field Wolbachia Mosquitoes
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Figure 3. Localization of Wolbachia in different A. aegypti tissues visualized using FISH. Outbred laboratory wMel (MGYP2.out) (A, C, G, E)
and field-released wMel (wMel.F) (B, D, F, H) mosquitoes at day 7 post DENV infection. Wolbachia stained in red (Alexa 594) and cell nuclei in blue
DENV Replication in Field Wolbachia Mosquitoes
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At day 14, virus titers in wildtype mosquitoes ranged from below
the limit of detection to 108 copies/mg of RNA whereas virus was
observed only in a few instances in field wMel. Only in one field
wMel individual was the maximum number of DENV copies
observed (Figure 2, strain 92T body and heads panels). Overall,
the results indicate that when breakthrough virus occurs in wMel
mosquitoes, viral titers are most likely to be lower than those
observed in wildtypes.
Wolbachia tissue tropism and density in field mosquitoes
We next investigated whether Wolbachia tissue tropism and
density had changed significantly in field wMel mosquitoes since
release in 2011. Using FISH, we found that Wolbachia was
distributed in the same tissues in field mosquitoes and in the
original wMel-transinfected laboratory line, MGYP2.out (Fig-
ure 3). In both wMel-infected lines, Wolbachia was present in two
tissues that are critical in viral infection and dissemination, namely
midguts and salivary glands (Figure 3 A–B & G–H). Wolbachia
was also present in brains, although not at high densities which
was consistent with levels expected for the wMel strain [9]. Field
wMel ovaries appeared highly infected with Wolbachia (Figure 3
D), indicating the potential for stable transmission of the bacteria
to offspring in the wild.
We also examined whether Wolbachia densities change following
blood-feeding in field wMel mosquitoes compared to the original
MGYP2.out line. By initially looking at whole mosquitoes we
found that, by day 7, the density of wMel had increased following
blood-feeding in both lines (Figure 4 A). A much higher increase
in Wolbachia density was observed in field wMel mosquitoes versus
MGYP2.out (Figure 4 A). Median ratios of wsp to RpS17 gene
copy numbers increased significantly from 0.714 and 0.702 in
non-blood fed wMel.F and MGYP2.out, respectively, to 1.465 and
1.241 in blood-fed wMel.F andMGYP2.out, respectively (Figure 4
A). The difference in Wolbachia density between blood-fed and
non-blood fed mosquitoes persisted at 14 days post feeding
(Figure 4 B), in the absence of repeat feeds. Median ratios of wsp
to RpS17 gene copy numbers were 0.649 and 0.733 in non-blood
fed wMel.F and MGYP2.out, respectively, compared to 1.542 and
1.675 in blood-fed wMel.F andMGYP2.out, respectively (Figure 4
B). Interestingly, by day 14, Wolbachia density continued to increase
in blood-fed MGYP2.out and field wMel mosquitoes compared to
non-blood fed ones, as indicated by the slightly higher median
values of normalized wsp/RpS17 ratios (Figure 4 B). Following
blood-feeding, increases in Wolbachia density in both field and
laboratory lines were primarily localized in the bodies rather than
heads (Figure 5), probably due to the bacteria replicating in
ovaries.
Discussion
Infection of the vector A. aegypti with Wolbachia has been pro-
posed as a dengue biocontrol method that is environmentally
friendly and able to spread unassisted in wild mosquito popula-
tions. Release of wMel-infected mosquitoes in north Queensland
has indicated that this Wolbachia strain can rapidly reach fixation
in wild populations [12]. Key to the utility of this biocontrol
method is the maintenance of DENV-blocking following mosquito
release and in subsequent generations as Wolbachia invades wild
populations.
Our results indicate that, one year post-release, field wMel
mosquitoes show significantly reduced DENV infection and repli-
cation compared to wildtype mosquitoes. Strikingly, we found very
low infection rates in mosquito heads, indicating that DENV is
largely unable to disseminate to the heads in wMel mosquitoes,
under the experimental conditions used here. By day 14, in both
experiments, wMel mosquitoes displayed dramatically reduced
infection rates and viral titers in heads compared to wildtype.
Reduced DENV dissemination and transmission rates due to the
(DAPI). Images are representative of 4–5 mosquitoes per line. Bars represent 50 mM scale.
doi:10.1371/journal.pntd.0002688.g003
Figure 4. Blood-feeding and Wolbachia densities in whole mosquitoes. Outbred laboratory wMel (MGYP2.out) and field-released wMel
(wMel.F) A. aegypti at 7 (A) and 14 (B) days post blood-feeding (BF) versus non-blood fed (NBF) controls. Bars denote medians. P,0.05 (*), P,0.01 (**),
P,0.001 (***). Each point represents an individual mosquito.
doi:10.1371/journal.pntd.0002688.g004
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presence of native Wolbachia endosymbionts have also been found
in the vector A. albopictus [27]. The pattern was observed with a
range of virus titers and serotypes (DENV-1 to -3), and using both
cell-cultured and viremic human plasma. We did not test for
systematic differences in response to these variables here, but work
with other viruses has indicated the extent of Wolbachia-mediated
viral blocking is dependent on virus titer [28].
Our data suggest stability of viral blocking and Wolbachia tissue
tropism since divergence of field mosquitoes from the parental
wMel-transinfected laboratory line MGYP2.out. We did not find
statistically significant differences in either dengue infection rates
or virus titers between field wMel and MGYP2.out mosquitoes.
However, field wMel mosquitoes may be somewhat better at
blocking dissemination of DENV-1 but not DENV-2 and DENV-
3 compared to MGYP2.out (Figure 2). This is because the
number of MGYP2.out individuals infected with virus is much
higher for DENV-1 than DENV-2 and DENV-3 compared to
field mosquitoes. Virus was detected in a higher number of
MGYP2.out individuals for DENV-1 strain P307, compared to the
other virus strains tested. Additional experiments are needed to
determine whether this effect is due to the particular strain or a
phenomenon general to the DENV-1 serotype. DENV-2-92T
dissemination rates in MGYP2.out were 12.5% several genera-
tions after transinfection in earlier work [9] and have stayed a low
7% in our study, at least 10 generations later and with frequent
outcrossing of this line (every three generations). This time frame is
comparable with that experienced by field mosquitoes, with the
maximum number of generations per year in Cairns being 15 and
populations persisting throughout the year [29]. MGYP2.out and
field wMel-infected mosquitoes have therefore retained the virus
blocking phenotype described in [9] that led to the field release of
Wolbachia-infected mosquitoes. Our results suggest that the virus
blocking phenotype induced by wMel may be retained not just
over the short term, but also over the medium to longer term.
Wolbachia tissue tropism was similar in field and laboratory
wMel-infected mosquitoes, with high densities of the bacterium
found in the midgut and ovaries. Wolbachia was also present in the
salivary glands and brains of both mosquito lines, which may
contribute to the limited dissemination and replication of DENV
observed in heads from the wMel-infected lines. In Drosophila
simulans, high Wolbachia densities in head and midgut have been
correlated with interference against Drosophila C virus [30].
Wolbachia density is critical in modulating transmission fidelity of
the bacterium across generations and pathogenicity [19]. Wolbachia
density changes dynamically in response to environmental
variables [31]. We also found that Wolbachia density increased
following blood-feeding, consistent with other studies that have
shown an increase in endosymbiont density in response to high
nutrient conditions [32]. Wolbachia provides a fitness benefit by
modulating iron levels in D. melanogaster [33] and responds trans-
criptionally to iron overload [34]. Increased Wolbachia replication
is most likely localized to the ovaries, although further work is
needed to confirm this. Our results differ, however, from those of
[35], who showed a blood-feeding induced reduction in the native
endosymbiont wFlu in the ovaries of the mosquito Aedes fluviatilis.
Surprisingly, the increase in Wolbachia density was more pro-
nounced in field wMel mosquitoes compared to the laboratory
line, although only at day 7 post-infection. The reasons for this
difference are unknown but may be related to poor nutrition in the
field or other environmental effects. Although mosquitoes were
reared in the same environment for one generation, maternal
nutritional effects can be detected up to several generations later in
insects [36,37]. Maternal effects due to poor nutrition in the field
may influence offspring immune status and the ability to control
infection levels, potentially resulting in higher Wolbachia densities.
Dynamic changes in Wolbachia density following blood-feeding
may have implications for vector competence of wMel-infected
mosquitoes. The precise mechanism by which Wolbachia mediates
viral blocking is not known but is positively related to density of the
bacterium [13,14,38]. If blood-feeding acts to increase Wolbachia
density and A. aegypti feed frequently on human hosts, viral
blocking may be greater in field populations than anticipated from
laboratory experiments, although further studies are needed to test
this hypothesis. In laboratory experiments involving Drosophila, the
density of Wolbachia has been shown to evolve to a level that is non-
pathogenic to the fly but the bacteria are still maintained [19,39].
Figure 5. Blood-feeding and Wolbachia densities in mosquito heads and bodies. Bodies (A) and heads (B) of outbred laboratory wMel
(MGYP2.out) and field-released wMel (wMel.F) A. aegypti at days 7 and 14 post blood-feeding. Bars denote medians. P,0.05 (*), P,0.01 (**), P,0.001
(***). Each point represents an individual mosquito.
doi:10.1371/journal.pntd.0002688.g005
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Understanding selection pressures on wMel-infected mosquitoes in
nature will be necessary to predict how Wolbachia may evolve over
the long term in field-released mosquitoes.
A. aegypti infected with Wolbachia show reduced replication of
other RNA viruses, such as yellow fever [28], chikungunya [8,28]
and West Nile [40] viruses. Wolbachia-based biocontrol may
therefore have the potential to eliminate transmission of old and
emerging arboviruses in addition to DENV. The maintenance of
virus blocking in field release mosquitoes is critical to the success of
Wolbachia-based biocontrol. Our results show that dengue virus
blocking and Wolbachia density phenotypes have stayed stable in
A. aegypti infected with wMel, at least 12 months following field
release.
Supporting Information
Figure S1 DENV replication in bodies (A) and heads (B) of
wildtype and field-released wMel (wMel.F) A. aegypti challenged
with three strains (DENV2-92T, DENV1-P249, DENV2-P410),
assayed at 7 days post-infection (experiment 1). DENV levels
determined using one-step qRT-PCR and expressed as copies per
1 mg of total RNA. Bars denote medians. P,0.05 (*), P,0.01 (**),
P,0.001 (***). Each point represents an individual mosquito.
(TIF)
Figure S2 DENV replication in bodies (A) and heads (B) of
wildtype, outbred laboratory wMel (MGYP2.out) and field-
released wMel (wMel.F) A. aegypti challenged with three strains
(DENV2-92T, DENV1-P307, DENV3-Cairns08/09), assayed at 7
days post-infection (experiment 2). DENV levels determined using
one-step qRT-PCR and expressed as copies per 1 mg of total
RNA. Bars denote medians. P,0.05 (*), P,0.01 (**), P,0.001
(***). Each point represents an individual mosquito.
(TIF)
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